Ex vivo Ikk β ablation rescues the immunopotency of mesenchymal stromal cells from diabetics with advanced atherosclerosis
ConclusionsConstitutively active IKK β reduces the immunopotency of atherosclerosis+T2DM MSC by changing their secretome composition. Modulation of IKKβ in atherosclerosis+T2DM MSCs enhances their myocardial repair ability.
Source: Cardiovascular Research - Category: Cardiology Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Gastroschisis Repair | Heart | Heart Attack